Add to Outlook 

 

download brochure


2012 Transforming Drug Development Brochure 
Final Brochure 

produced by

AptivSolutions 

 

Berry Consultants 

 

TessellaNEW 

 


Significant advances have been made in the design and execution of adaptive clinical trials. Advances that are being implemented throughout the industry, bringing desperately needed change to drug and medical device development. These changes are focused on the needs and opportunities to innovate in drug development, bringing about increased efficiency and improved decision making, and ultimately increasing the likelihood of bringing beneficial therapies to market.

There has been a lot of hype and mixed messages around adaptive designs. Attend the Transforming Drug Development: Delivering Innovation and Efficiency through Clinical Trials conference to better understand both the promise of adaptive trials and the required caution.

The conference will bring together experts in the economics and management of the pharmaceutical industry, drug developers, and adaptive trial designers and implementers to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess their potential for transforming drug development.

Who Should Attend:

• CEOs, CMOs, CSOs
• R&D Decision Makers in Drug Development
• Therapy Area Heads
• Medical Experts
• Product Portfolio Managers
• Senior Clinical Operations Managers
• Senior Biostatisticians
• Pharmacologists
• Regulatory Affairs Managers

chairpersons

Professor Andy Grieve,
Senior Vice President, Clinical Trial Methodology, Aptiv Solutions

Roger Lewis, MD, Ph.D.,
Professor of Emergency Medicine Harbor-UCLA Medical Center Senior Medical Scientist, Berry Consultants, LLC

speakers

Kenneth Getz,
Senior Research Fellow, Director of Sponsored Programs, Tufts CSDD Chairman, CISCRP

Don Berry, Ph.D.,
Professor of Biostatistics, University of Texas MD Anderson Cancer Center; Founder and Senior Statistical Scientist, Berry Consultants, LLC

Scott Berry, Ph.D.,
President & Senior Statistical Scientist, Berry Consultants, LLC

Tom Parke,
Head, Clinical Trial Solutions, Tessella

Vlad Dragalin, Ph.D.,
Senior Vice President, Innovation Center, Aptiv Solutions

Brenda L. Gaydos, Ph.D.,
Research Fellow & Head, Clinical Trial Optimization, Eli Lilly

Mike Krams, M.D.,
Vice President & Head, Neurology Franchise, Johnson & Johnson

Steve Arlington, Ph.D.,
Global Advisory Leader, Pharmaceuticals and Life Sciences, PwC

Scott Gottlieb,
Research Fellow, American Enterprise Institute